Titre:
  • Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects.
Auteur:Suarez-Carmona, Meggy; Williams, Anja; Schreiber, Jutta; Hohmann, Nicolas; Pruefer, Ulrike; Krauss, Jürgen; Jäger, Dirk; Frömming, Anna; Beyer, Diana; Eulberg, Dirk; Jungelius, Jarf Ulf; Baumann, Matthias; Mangasarian, Aram; Halama, Niels
Informations sur la publication:Journal for ImmunoTherapy of Cancer, 9, 10
Statut de publication:Publié, 2021-10-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:combination
cytokines
drug therapy
gastrointestinal neoplasms
immunotherapy
translational medical research
MeSH keywords:Aged
Aged, 80 and over
Chemokine CXCL12 -- antagonists & inhibitors
Colorectal Neoplasms -- drug therapy
Female
Humans
Immunotherapy -- methods
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy
Programmed Cell Death 1 Receptor -- antagonists & inhibitors
Langue:Anglais
Identificateurs:urn:issn:2051-1426
info:doi/10.1136/jitc-2021-002505
info:pii/jitc-2021-002505
info:pmid/34607895
PMC8491418